KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Long-Term Debt Issuances (2017 - 2025)

Elevance Health (ELV) has disclosed Long-Term Debt Issuances for 15 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Issuances fell 100.06% to -$3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.1 billion, a 5.33% increase, with the full-year FY2025 number at $3.0 billion, down 61.21% from a year prior.
  • Long-Term Debt Issuances was -$3.0 million for Q4 2025 at Elevance Health, down from $3.0 billion in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $5.1 billion in Q4 2024 to a low of -$14.0 million in Q3 2022.
  • A 5-year average of $2.2 billion and a median of $2.6 billion in 2023 define the central range for Long-Term Debt Issuances.
  • Peak YoY movement for Long-Term Debt Issuances: skyrocketed 1054.0% in 2021, then tumbled 100.06% in 2025.
  • Elevance Health's Long-Term Debt Issuances stood at $3.5 billion in 2021, then plummeted by 48.44% to $1.8 billion in 2022, then soared by 44.2% to $2.6 billion in 2023, then skyrocketed by 99.3% to $5.1 billion in 2024, then crashed by 100.06% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Long-Term Debt Issuances are -$3.0 million (Q4 2025), $3.0 billion (Q3 2025), and $5.1 billion (Q4 2024).